Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors
Open Access
- 18 August 2016
- journal article
- Published by Springer Nature in Leukemia
- Vol. 30 (11) , 2280-2281
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive RasLeukemia, 2016
- RAS diseases in childrenHaematologica, 2014
- Clonal architecture of chronic myelomonocytic leukemiasBlood, 2013
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survivalAnnals of Hematology, 2003
- Interleukin-10 Inhibits Spontaneous Colony-Forming Unit–Granulocyte-Macrophage Growth From Human Peripheral Blood Mononuclear Cells by Suppression of Endogenous Granulocyte-Macrophage Colony-Stimulating Factor ReleaseBlood, 1997
- Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.Journal of Experimental Medicine, 1996
- Colony growth characteristics in chronic myelomonocytic leukemiaLeukemia Research, 1988